EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pulmonary Drug Delivery for Infectious Diseases: Cutting-Edge Formulations and Manufacturing Technologies

Brayan J Anaya iD, Emanuel Osorio-Vargas, Samir Monterrosa-Moreno, Diego F Tirado iD, Elena González-Burgos iD, Dolores R Serrano iD

Pharmaceutics · 14.02.2026 · 18 (2) · 242

DOI: 10.3390/pharmaceutics18020242 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 14.02.2026. Verfasst von Brayan J Anaya und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutics and Food Technology Department, Faculty of Pharmacy, Universidad Complutense de Madrid, Plaza Ramón y Cajal s/n, 28040 Madrid, Spain. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 326 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia, Innovación y Universidades, universidad complutense de Madrid, Ministerio de Ciencia, Tecnología e Innovación.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary drug delivery has emerged as a powerful strategy for the treatment of respiratory infectious diseases, including bacterial, fungal, and viral infections such as influenza and COVID-19, by enabling high local drug concentrations while minimizing systemic exposure. However, the clinical success of inhaled anti-infective therapies critically depends on the precise engineering of particle properties that govern lung deposition, cellular targeting, and therapeutic efficacy. In this review, we provide a comprehensive and technology-driven overview of cutting-edge formulation and manufacturing strategies for pulmonary drug delivery, with particular emphasis on the key process and formulation parameters required to generate effective inhalable systems for the treatment of infectious diseases. Advanced particle-engineering approaches, including spray drying, spray freeze drying, jet milling, and supercritical fluid technologies are discussed as enabling tools to tightly control aerodynamic particle size, morphology, and solid-state properties. In parallel, emerging platforms such as nanoparticle-based delivery systems are examined for their ability to target specific lung cell populations, including epithelial cells and alveolar macrophages, thereby enhancing antimicrobial efficacy. Finally, innovative manufacturing concepts such as microfluidics and three-dimensional (3D) printing are highlighted as promising strategies to improve particle size uniformity, reproducibility, and formulation customization. By integrating formulation science with advanced manufacturing technologies, this review identifies the critical design and processing parameters that underpin effective pulmonary delivery of anti-infective therapies and outlines future directions for the development of next-generation inhaled treatments.

Schlagwörter

Stichwörter der Autor:innen

3D printing use in lung therapyaerodynamic propertiesinfectious respiratory diseaseslung-on-a-chipparticle engineeringpulmonary drug delivery

Autor:innen und Institutionen

  • Pharmaceutics and Food Technology Department, Faculty of Pharmacy, Universidad Complutense de Madrid, Plaza Ramón y Cajal s/n, 28040 Madrid, Spain.
  • Biological Engineering Program, Dirección Académica, Universidad Nacional de Colombia, Sede de La Paz, La Paz 202017, Colombia.
  • Insumos y Equipos JR, Cartagena 130001, Colombia.
  • Facultad de ingeniería, Universidad de Cartagena, Cartagena 130002, Colombia.
  • Department of Pharmacology, Pharmacognosy and Botany, Faculty of Pharmacy, Universidad Complutense de Madrid, 28040 Madrid, Spain.
  • Instituto Universitario de Farmacia Industrial, Faculty of Pharmacy, Universidad Complutense de Madrid, 28040 Madrid, Spain.

ORCID-Profile: Brayan J Anaya, Diego F Tirado, Elena González-Burgos, Dolores R Serrano

Förderung

  • Ministerio de Ciencia, Innovación y Universidades
  • universidad complutense de Madrid
  • Ministerio de Ciencia, Tecnología e Innovación
  • Research group FARM3D
  • Ministry of Science, Innovation, and Universities of Spain and Agencia Española de Investigación
  • Ministerio de Ciencia Tecnología e Innovación (MinCiencias) of Colombia

Zitieren

APA

Anaya, B. J., Osorio-Vargas, E., Monterrosa-Moreno, S., Tirado, D. F., González-Burgos, E., & Serrano, D. R. (2026). Pulmonary Drug Delivery for Infectious Diseases: Cutting-Edge Formulations and Manufacturing Technologies. Pharmaceutics, 18(2), 242. https://doi.org/10.3390/pharmaceutics18020242

Vancouver

Anaya BJ, Osorio-Vargas E, Monterrosa-Moreno S, Tirado DF, González-Burgos E, Serrano DR. Pulmonary Drug Delivery for Infectious Diseases: Cutting-Edge Formulations and Manufacturing Technologies. Pharmaceutics. 2026;18(2):242. doi:10.3390/pharmaceutics18020242

BibTeX
@article{Anaya2026,
  author = {Anaya, Brayan J and Osorio-Vargas, Emanuel and Monterrosa-Moreno, Samir and Tirado, Diego F and González-Burgos, Elena and Serrano, Dolores R},
  title = {Pulmonary Drug Delivery for Infectious Diseases: Cutting-Edge Formulations and Manufacturing Technologies},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {2},
  pages = {242},
  doi = {10.3390/pharmaceutics18020242}
}
Kostenlos starten →